The heterozygous NUDT15 variant is not associated with the severity of 6-mercaptopurine-related side effects in early intensification therapy for childhood acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The heterozygous NUDT15 variant is not associated with the severity of 6-mercaptopurine-related side effects in early intensification therapy for childhood acute lymphoblastic leukemia

Published:2023 Issue: Volume:1 Page:100006
ISSN:2772-610X
Container-title:EJC Paediatric Oncology
language:en
Short-container-title:EJC Paediatric Oncology

Author:

Zhao Jimei,Ueki Masahiro^ORCID,Sawai Saori,Sugiyama Minako^ORCID,Terashita Yukayo,Hirabayashi Shinsuke,Cho Yuko,Kobayashi Ryoji,Tanaka Yoichi,Manabe Atsushi^ORCID

Publisher

Elsevier BV

Reference19 articles.

1. Treatment and biology of pediatric acute lymphoblastic leukemia;Kato;Pediatr. Int.,2018

2. Pediatric acute lymphoblastic leukemia;Brown;J. Natl. Compr. Cancer Netw.,2020

3. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002;Stary;J. Clin. Oncol.,2014

4. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia;Jun;J. Clin. Oncol.,2015

5. Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia;Tanaka;Br. J. Haematol.,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy;British Journal of Clinical Pharmacology;2024-07-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP